The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Timasheva Y.R.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre;
Bashkir State Medical University

Nasibullin T.R.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre

Tuktarova I.A.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre

Erdman V.V.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre

Galiullin T.R.

Bashkir State Medical University

Lyutov O.V.

Bashkir State Medical University

Bakhtiyarova K.Z.

Bashkir State Medical University

Multiple sclerosis in the Republic of Bashkortostan: population-specific genetic predictors and the results of a 20-year clinical follow-up study

Authors:

Timasheva Y.R., Nasibullin T.R., Tuktarova I.A., Erdman V.V., Galiullin T.R., Lyutov O.V., Bakhtiyarova K.Z.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7‑2): 34‑42

DOI: 10.17116/jnevro202312307234

Read: 2393 times

Download PDF (RU)
Contact the author
Table of contents

MULTIPLE SCLEROSIS IN THE REPUBLIC OF BASHKORTOSTAN: POPULATION-SPECIFIC GENETIC PREDICTORS AND THE RESULTS OF A 20-YEAR CLINICAL FOLLOW-UP STUDY
MULTIPLE SCLEROSIS IN THE REPUBLIC OF BASHKORTOSTAN: POPULATION-SPECIFIC GENETIC PREDICTORS AND THE RESULTS OF A 20-YEAR CLINICAL FOLLOW-UP STUDY

To cite this article:

Timasheva YR, Nasibullin TR, Tuktarova IA, Erdman VV, Galiullin TR, Lyutov OV, Bakhtiyarova KZ. Multiple sclerosis in the Republic of Bashkortostan: population-specific genetic predictors and the results of a 20-year clinical follow-up study. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7‑2):34‑42. (In Russ.)
https://doi.org/10.17116/jnevro202312307234

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Low-level laser therapy in multiple scle­rosis: justification and opti­mization methods of application. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):45-56
Glial fibrillary acidic protein: is there a rela­tionship with the course of multiple scle­rosis and traumatic brain injury before the onset of multiple scle­rosis?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):80-84
An indi­vidual approach to the diagnosis and treatment of an acute psychotic condition in a patient with a multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):97-102
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
Comparing the effi­cacy of divo­zilimab and second-line treatments for rela­psing-remitting multiple scle­rosis in the Russian Fede­ration: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Abstract:

OBJECTIVE

Identification of a complex of genetic predictors of multiple sclerosis (MS) based on previously obtained results in genome-wide association studies of disease markers (GWAS markers) in a population of MS patients and healthy individuals of the Republic of Bashkortostan (Russian Federation) using polygenic detection.

MATERIAL AND METHODS

The total study group consisted of 2048 people (641 patients with MS and 1407 healthy individuals) who permanently resided in the Republic of Bashkortostan and belonged to the Bashkir (n=325), Russian (n=772) or Tatar (n=951) nationalities. The analysis of association between MS and polymorphisms previously associated with the disease according to GWAS data was performed. Of the 641 MS patients, 247 were the subject of a 20-year prospective clinical follow-up.

RESULTS

The C6orf10 rs3129934*T allele was most significantly associated with MS in Russians (OR=2.00, P=5.85·10–5) and Tatars (OR=2.38, P=8.61·10–7). An increased MS risk in Russians was also associated with the EOMES rs11129295*T (OR=1.56, P=0.007) and IL7R rs1494558*I (OR=1.61, P=0.003) alleles. Meta-analysis confirmed the association of the C6orf10 rs3129934*T, EOMES rs11129295*T and IL7R rs1494558*I alleles with MS in the total group, as well as revealed associations of the INAVA rs7522462*G, IL7R rs10624573*I, CD6 rs17824933*G, GPC5 rs9523762*A and GPR65 rs2119704*C alleles with the disease. Using polygenic analysis, we identified a complex predictor C6orf10 rs3129934*C + INAVA rs7522462*G + CD6 rs17824933*C with a pronounced protective effect against MS in the total group (OR=0.34, PFDR=2.65·10–7).

CONCLUSION

We reproduced the association of eight polymorphisms (C6orf10 rs3129934, INAVA rs7522462, IL7R rs10624573, EOMES rs11129295, GPR65 rs2119704, GPC5 rs9523762, CD6 rs17824933 and CD58 rs2300747) with MS, previously identified in GWAS in European populations. Whole exome or genome sequencing may help to reveal the mechanisms underlying the pathogenesis of MS in populations of the Russian Federation.

Keywords:

multiple sclerosis
genome-wide association signals
human leukocyte antigen
major histocompatibility region

Authors:

Timasheva Y.R.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre;
Bashkir State Medical University

Nasibullin T.R.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre

Tuktarova I.A.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre

Erdman V.V.

Institute of Biochemistry and Genetics of Ufa Federal Research Centre

Galiullin T.R.

Bashkir State Medical University

Lyutov O.V.

Bashkir State Medical University

Bakhtiyarova K.Z.

Bashkir State Medical University

Received:

24.05.2023

Accepted:

02.06.2023

Close metadata

References:

  1. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis Journal. 2020;26(14):1816-1821. https://doi.org/10.1177/1352458520970841
  2. Hafler DA, Kompsten A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. New England Journal of Medicine. 2007;357(9):851-862.  https://doi.org/10.1056/NEJMoa073493
  3. Comabella M, Craig DW, Camina-Tato M, et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One. 2008;3(10):e3490. https://doi.org/10.1371/journal.pone.0003490
  4. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009;41(7):776-782.  https://doi.org/10.1038/ng.401
  5. Patsopoulos NA, Esposito F, Reischl J, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol. 2011;70(6):897-912.  https://doi.org/10.1002/ana.22609
  6. Lvovs D, Favorova OO, Favorov AV. A polygenic approach to the study of polygenic diseases. Acta Naturae. 2012;4(3):59-71. 
  7. Boyko A. Melnikov M. Prevalence and Incidence of Multiple Sclerosis In Russian Federation: 30 Years of Studies. Brain Sciences. 2020;10(5):305.  https://doi.org/10.3390/brainsci10050305
  8. Bakhtiiarova KZ, Goncharova ZA. Multiple sclerosis in the Bashkortostan Republic and the Rostov region: a comparative epidemiologic study. J Neurol Psychiatry im. S.S. Korsakova. 2014;114(2 vyp 2):5-9. (In Russ.).
  9. Bakhtiiarova KZ, Magzhanov RV. Multiple sclerosis in the ethnic groups of the Republic of Bashkortostan. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2006;106(3):17-21. (In Russ.).
  10. Timasheva YR, Zaplakhova OV, Nasibullin TR, et al. Association between Allelic Variants of IL2, IL2RA, and IL7R Genes and Multiple Sclerosis.. Russian Journal of Genetics. 2019;55(4):487-494. 
  11. Timasheva YR, Nasibullin TR, Tuktarova IA, et al. The analysis of association between multiple sclerosis and genetic markers identified in genome-wide association studies. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(7. Vyp. 2):54-60. (In Russ.).
  12. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics. 2007;81(3):559-575.  https://doi.org/10.1086/519795
  13. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the royal statistical society. Series B (Methodological). 1995;289-300.  https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
  14. Favorov AV, Andreewski TV, Sudomoina MA, et al. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans. Genetics. 2005;171(4):2113-2121. https://doi.org/10.1534/genetics.105.048090
  15. Martinelli-Boneschi F, Esposito F, Brambilla P, et al. A genome-wide association study in progressive multiple sclerosis. Mult Scler. 2012;18(10):1384-1394. https://doi.org/10.1177/1352458512439118
  16. Patsopoulos NA, Xifara DK, Davis MF, et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188. https://doi.org/10.1126/science.aav7188
  17. Beecham AH, Patsopoulos NA, Xifara DK, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics. 2013;45(11):1353-1360. https://doi.org/10.1038/ng.2770
  18. Yan J, Hedl M, Abraham C. An inflammatory bowel disease—risk variant in INAVA decreases pattern recognition receptor—induced outcomes. The Journal of Clinical Investigation. 2017;127(6):2192-2205. https://doi.org/10.1172/JCI86282
  19. Timasheva Y, Nasibullin TR, Tuktarova IA, et al. Multilocus Evaluation of Genetic Predictors of Multiple Sclerosis. Gene. 2021;146008. https://doi.org/10.1016/j.gene.2021.146008
  20. Suhre K, Arnold M, Bhagwat AM, et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun. 2017;8:14357. https://doi.org/10.1038/ncomms14357
  21. Gruarin P, Maglie S, De Simone M, et al. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells. European Journal of Immunology. 2019;49(1):96-111.  https://doi.org/10.1002/eji.201847722
  22. Reiser J, Sadashivaiah K, Furusawa A, et al. Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype. Cellular Immunology. 2019;335:93-102.  https://doi.org/10.1016/j.cellimm.2018.11.008
  23. Parnell GP, Gatt PN, Krupa M, et al. The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology. 2014;151(1):16-24.  https://doi.org/10.1016/j.clim.2014.01.003
  24. Chen S, Zhang J, Liu QB, et al. Variant of EOMES Associated with Increasing Risk in Chinese Patients with Relapsing-remitting Multiple Sclerosis. Chinese Medical Journal. 2018;131(6):643-647.  https://doi.org/10.4103/0366-6999.226892
  25. Cavanillas ML, Fernández O, Comabella M, et al. Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes & Immunity. 2011;12(2):110-115.  https://doi.org/10.1038/gene.2010.52
  26. Johnson BA, Wang J, Taylor EM, et al. Multiple sclerosis susceptibility alleles in African Americans. Genes & Immunity. 2010;11(4):343-350.  https://doi.org/10.1038/gene.2009.81
  27. Baranzini SE, Wang J, Gibson RA, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human Molecular Genetics. 2009;18(4):767-778.  https://doi.org/10.1093/hmg/ddn388
  28. De Jager PL, Baecher-Allan C, Maier LM, et al. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci USA. 2009;106(13):5264-5269. https://doi.org/10.1073/pnas.0813310106
  29. Wagner M, Bilinska M, Pokryszko-Dragan A, et al. ALCAM and CD6 — multiple sclerosis risk factors. Journal of Neuroimmunology. 2014;276(1):98-103.  https://doi.org/10.1016/j.jneuroim.2014.08.621
  30. Kofler DM, Severson CA, Mousissian N, et al. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation. Journal of Immunology. 2011;187(6):3286-3291. https://doi.org/10.4049/jimmunol.1100626
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.